volume 18 issue 4 pages 394-405

Stroke in China: advances and challenges in epidemiology, prevention, and management

Simiao Wu
Bo Wu
Ming Liu
Zhengming Chen
Wenzhi Wang
Craig S. Anderson
Peter Sandercock
Yongjun Wang
Yining Huang
Liying Cui
Chuanqiang Pu
Jianping Jia
Tong Zhang
Xinfeng Liu Xinfeng
Suming Zhang
Peng Xie
Dongsheng Fan
Xunming Ji
Ka Sing Lawrence Wong
Longde Wang
Chenchen Wei
Yanan Wang
Yajun Cheng
Yunhai Liu
Xin Li
Qiang Dong
Jinsheng Zeng
Bin Peng
Yun Xu
Y Yang
Yilong Wang
Gang Zhao
Wei Wang
YUMING XU
Qingwu Yang
Zhiyi He
Shaoshi Wang
Chao You
Ying Gao
Dong Zhou
Li He
Zixiao Li
Jie Yang
Chunyan Lei
YUHUA ZHAO
Junfeng Liu
Shuting Zhang
Wendan Tao
Zilong Hao
DEREN WANG
Shihong Zhang
Publication typeJournal Article
Publication date2019-04-01
scimago Q1
wos Q1
SJR11.729
CiteScore62.6
Impact factor45.5
ISSN14744422, 14744465
Neurology (clinical)
Abstract
With over 2 million new cases annually, stroke is associated with the highest disability-adjusted life-years lost of any disease in China. The burden is expected to increase further as a result of population ageing, an ongoing high prevalence of risk factors (eg, hypertension), and inadequate management. Despite improved access to overall health services, the availability of specialist stroke care is variable across the country, and especially uneven in rural areas. In-hospital outcomes have improved because of a greater availability of reperfusion therapies and supportive care, but adherence to secondary prevention strategies and long-term care are inadequate. Thrombolysis and stroke units are accepted as standards of care across the world, including in China, but bleeding-risk concerns and organisational challenges hamper widespread adoption of this care in China. Despite little supporting evidence, Chinese herbal products and neuroprotective drugs are widely used, and the increased availability of neuroimaging techniques also results in overdiagnosis and overtreatment of so-called silent stroke. Future efforts should focus on providing more balanced availability of specialised stroke services across the country, enhancing evidence-based practice, and encouraging greater translational research to improve outcome of patients with stroke.
Found 
Found 

Top-30

Journals

20
40
60
80
100
120
Frontiers in Neurology
102 publications, 8.18%
Medicine (United States)
27 publications, 2.17%
BMC Neurology
27 publications, 2.17%
Scientific Reports
23 publications, 1.84%
BMJ Open
22 publications, 1.76%
Frontiers in Pharmacology
21 publications, 1.68%
Heliyon
17 publications, 1.36%
Brain and Behavior
16 publications, 1.28%
Frontiers in Public Health
15 publications, 1.2%
Stroke and Vascular Neurology
14 publications, 1.12%
Journal of Stroke and Cerebrovascular Diseases
13 publications, 1.04%
Journal of the American Heart Association
12 publications, 0.96%
Frontiers in Neuroscience
12 publications, 0.96%
Frontiers in Aging Neuroscience
12 publications, 0.96%
Evidence-based Complementary and Alternative Medicine
10 publications, 0.8%
Brain Sciences
10 publications, 0.8%
BMC Public Health
10 publications, 0.8%
PLoS ONE
10 publications, 0.8%
CNS Neuroscience and Therapeutics
9 publications, 0.72%
Neuropsychiatric Disease and Treatment
9 publications, 0.72%
Neurology
8 publications, 0.64%
Chinese Medical Journal
8 publications, 0.64%
International Journal of Stroke
8 publications, 0.64%
Frontiers in Cellular Neuroscience
8 publications, 0.64%
Neurological Sciences
8 publications, 0.64%
The Lancet Regional Health - Western Pacific
8 publications, 0.64%
International Journal of General Medicine
8 publications, 0.64%
Neurological Research
8 publications, 0.64%
Cerebrovascular Diseases
7 publications, 0.56%
20
40
60
80
100
120

Publishers

50
100
150
200
250
Elsevier
223 publications, 17.88%
Springer Nature
218 publications, 17.48%
Frontiers Media S.A.
208 publications, 16.68%
Wiley
93 publications, 7.46%
Taylor & Francis
78 publications, 6.26%
Ovid Technologies (Wolters Kluwer Health)
74 publications, 5.93%
MDPI
43 publications, 3.45%
BMJ
38 publications, 3.05%
Hindawi Limited
37 publications, 2.97%
SAGE
32 publications, 2.57%
Institute of Electrical and Electronics Engineers (IEEE)
19 publications, 1.52%
JMIR Publications
13 publications, 1.04%
Public Library of Science (PLoS)
11 publications, 0.88%
AME Publishing Company
11 publications, 0.88%
S. Karger AG
10 publications, 0.8%
Research Square Platform LLC
8 publications, 0.64%
Bentham Science Publishers Ltd.
7 publications, 0.56%
Oxford University Press
7 publications, 0.56%
Hans Publishers
7 publications, 0.56%
Impact Journals
6 publications, 0.48%
Baishideng Publishing Group
5 publications, 0.4%
American Medical Association (AMA)
5 publications, 0.4%
China Science Publishing & Media
4 publications, 0.32%
Mary Ann Liebert
3 publications, 0.24%
PeerJ
3 publications, 0.24%
Georg Thieme Verlag KG
3 publications, 0.24%
American Chemical Society (ACS)
3 publications, 0.24%
Japan Atherosclerosis Society
3 publications, 0.24%
Pleiades Publishing
3 publications, 0.24%
50
100
150
200
250
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.2k
Share
Cite this
GOST |
Cite this
GOST Copy
Wu S. et al. Stroke in China: advances and challenges in epidemiology, prevention, and management // The Lancet Neurology. 2019. Vol. 18. No. 4. pp. 394-405.
GOST all authors (up to 50) Copy
Wu S. et al. Stroke in China: advances and challenges in epidemiology, prevention, and management // The Lancet Neurology. 2019. Vol. 18. No. 4. pp. 394-405.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S1474-4422(18)30500-3
UR - https://doi.org/10.1016/S1474-4422(18)30500-3
TI - Stroke in China: advances and challenges in epidemiology, prevention, and management
T2 - The Lancet Neurology
AU - Wu, Simiao
AU - Wu, Bo
AU - Liu, Ming
AU - Chen, Zhengming
AU - Wang, Wenzhi
AU - Anderson, Craig S.
AU - Sandercock, Peter
AU - Wang, Yongjun
AU - Huang, Yining
AU - Cui, Liying
AU - Pu, Chuanqiang
AU - Jia, Jianping
AU - Zhang, Tong
AU - Liu Xinfeng, Xinfeng
AU - Zhang, Suming
AU - Xie, Peng
AU - Fan, Dongsheng
AU - Ji, Xunming
AU - Wong, Ka Sing Lawrence
AU - Wang, Longde
AU - Wei, Chenchen
AU - Wang, Yanan
AU - Cheng, Yajun
AU - Liu, Yunhai
AU - Li, Xin
AU - Dong, Qiang
AU - Zeng, Jinsheng
AU - Peng, Bin
AU - Xu, Yun
AU - Yang, Y
AU - Wang, Yilong
AU - Zhao, Gang
AU - Wang, Wei
AU - XU, YUMING
AU - Yang, Qingwu
AU - He, Zhiyi
AU - Wang, Shaoshi
AU - You, Chao
AU - Gao, Ying
AU - Zhou, Dong
AU - He, Li
AU - Li, Zixiao
AU - Yang, Jie
AU - Lei, Chunyan
AU - ZHAO, YUHUA
AU - Liu, Junfeng
AU - Zhang, Shuting
AU - Tao, Wendan
AU - Hao, Zilong
AU - WANG, DEREN
AU - Zhang, Shihong
PY - 2019
DA - 2019/04/01
PB - Elsevier
SP - 394-405
IS - 4
VL - 18
PMID - 30878104
SN - 1474-4422
SN - 1474-4465
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Wu,
author = {Simiao Wu and Bo Wu and Ming Liu and Zhengming Chen and Wenzhi Wang and Craig S. Anderson and Peter Sandercock and Yongjun Wang and Yining Huang and Liying Cui and Chuanqiang Pu and Jianping Jia and Tong Zhang and Xinfeng Liu Xinfeng and Suming Zhang and Peng Xie and Dongsheng Fan and Xunming Ji and Ka Sing Lawrence Wong and Longde Wang and Chenchen Wei and Yanan Wang and Yajun Cheng and Yunhai Liu and Xin Li and Qiang Dong and Jinsheng Zeng and Bin Peng and Yun Xu and Y Yang and Yilong Wang and Gang Zhao and Wei Wang and YUMING XU and Qingwu Yang and Zhiyi He and Shaoshi Wang and Chao You and Ying Gao and Dong Zhou and Li He and Zixiao Li and Jie Yang and Chunyan Lei and YUHUA ZHAO and Junfeng Liu and Shuting Zhang and Wendan Tao and Zilong Hao and DEREN WANG and others},
title = {Stroke in China: advances and challenges in epidemiology, prevention, and management},
journal = {The Lancet Neurology},
year = {2019},
volume = {18},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/S1474-4422(18)30500-3},
number = {4},
pages = {394--405},
doi = {10.1016/S1474-4422(18)30500-3}
}
MLA
Cite this
MLA Copy
Wu, Simiao, et al. “Stroke in China: advances and challenges in epidemiology, prevention, and management.” The Lancet Neurology, vol. 18, no. 4, Apr. 2019, pp. 394-405. https://doi.org/10.1016/S1474-4422(18)30500-3.